We use cookies to provide you with a better experience. By clicking the Accept button, you are agreeing to our use of cookies in accordance with our Privacy Policy.
The FDA last week updated its March guidance on managing clinical trials during COVID-19 by saying that sites can conduct patient visits via video conference with some advance planning. Read More
President Trump on Friday outlined a strikingly ambitious plan to have a COVID-19 vaccine approved by the FDA and starting to be deployed by year’s end. Read More
COVID-19 has caused nearly half of all trial disruptions in the past five months, with oncology trials being hardest-hit, according to a new study out of Berlin. Read More
The severity of the COVID-19 pandemic could justify the use of human challenge studies in vaccine development, and their careful use may be worth considering if they’re conducted the right way, a medical ethics expert argued. Read More
To support research teams at sites struggling with the impact of COVID-19, the Association of Clinical Research Professionals (ACRP) has set up a Clinical Research Site Sustainability Fund to provide grants to sites for continuing education and career development resources. Read More
A new survey of investigator sites reveals approximately 69 percent of respondents said lockdown measures have impacted their ability to conduct ongoing trials and 78 percent said COVID-19 has affected their ability to start new trials. Read More
The COVID-19 Collaboration Platform (COVIDCP), a new initiative from universities and clinical trial organizations across the U.S., will bring together research teams who are working on vaccines and treatments for COVID-19. Read More
Pharma companies and CROs are experiencing ups and downs in the second quarter of 2020, with some fighting to keep their trials afloat amidst pandemic uncertainties while others are slowly getting back on track. Read More
A working group of the World Health Organization (WHO) has indicated its support of COVID-19 vaccine challenge studies, but made it clear that those trials must meet eight conditions for them to be considered. Read More
RSS
